Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Association of Syntax Score II with Contrast-induced Nephropathy and Hemodialysis Requirement in Patients with ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

  • Received : 2017.03.17
  • Accepted : 2017.09.26
  • Published : 2018.01.31
⟨ Previous Next ⟩

Abstract

Background and Objectives: Contrast-induced nephropathy (CIN) is a common complication of primary percutaneous coronary intervention (pPCI) and is associated with high mortality and morbidity and long hospital stay in patients with ST elevation myocardial infarction (STEMI). The Syntax Score (SS) has previously been studied in STEMI patients, and it was associated with increased CIN development and long-term mortality. This study investigates a possible relationship between CIN development and Syntax Score II (SSII) and compares SS and SSII by assessing CIN risk in STEMI patients treated with pPCI. Methods: A total of 1,234 patients who underwent pPCI were divided into 2 groups according to CIN development. Patients with CIN were further divided into 2 groups according to whether or not they required hemodialysis. Reclassification tables, net reclassification improvement, and integrated discriminative improvement methods were used to assess the additive predictive value of SSII for predicting CIN. Results: In the present study, 166 patients (13.5%) had CIN. Although both SS and SSII were significantly higher in CIN patients, only SSII was an independent predictor of CIN (odds ratio [OR], 1.031; 95% confidence interval [CI], 1.012-1.051; p<0.001) and hemodialysis requirement (OR, 1.078; 95% CI, 1.046-1.078; p<0.001). When comparing SSII and SS in their ability to determine CIN risk, we found SSII to have a reclassification improvement of 27.59% (p<0.001) and an integrated discrimination improvement of 9.1% (p<0.001). Conclusions: The combination of clinical and anatomic variables can more accurately identify patients who are at high risk for CIN after pPCI. While SSII is harder to calculate than SS, it provides better prediction for CIN and hemodialysis requirement than SS.

Keywords

References

  1. Xhepa E, Tada T, Kufner S, et al. Long-term prognostic value of risk scores after drug-eluting stent implantation for unprotected left main coronary artery: a pooled analysis of the ISAR-LEFT-MAIN and ISAR-LEFT-MAIN 2 randomized clinical trials. Catheter Cardiovasc Interv 2017;89:1-10. https://doi.org/10.1002/ccd.26645
  2. Gupta R, Gurm HS, Bhatt DL, Chew DP, Ellis SG. Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv 2005;64:442-8. https://doi.org/10.1002/ccd.20316
  3. Liss P, Persson PB, Hansell P, Lagerqvist B. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int 2006;70:1811-7. https://doi.org/10.1038/sj.ki.5001887
  4. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393-9.
  5. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008;51:1419-28. https://doi.org/10.1016/j.jacc.2007.12.035
  6. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-75. https://doi.org/10.1016/S0002-9343(97)00150-2
  7. Oduncu V, Erkol A, Karabay CY, et al. Relation of the severity of contrast induced nephropathy to SYNTAX score and long term prognosis in patients treated with primary percutaneous coronary intervention. Int J Cardiol 2013;168:3480-5. https://doi.org/10.1016/j.ijcard.2013.04.166
  8. Elbasan Z, Şahin DY, Gür M, et al. Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Angiology 2014;65:37-42. https://doi.org/10.1177/0003319712463816
  9. Wang G, Wang C, Zhang Y, et al. Usefulness of the SYNTAX score II to predict 1-year outcome in patients with primary percutaneous coronary intervention. Coron Artery Dis 2016;27:483-9. https://doi.org/10.1097/MCA.0000000000000385
  10. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)Steg PG, James SK, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-619. https://doi.org/10.1093/eurheartj/ehs215
  11. Thomsen HS. Guidelines for contrast media from the European Society of Urogenital Radiology. AJR Am J Roentgenol 2003;181:1463-71. https://doi.org/10.2214/ajr.181.6.1811463
  12. Kim SM, Tripathy DR, Park SW, et al. Impact of chronic kidney disease on clinical outcomes in diabetic patients undergoing percutaneous coronary intervention in the era of newer-generation drug-eluting stents. Korean Circ J 2017;47:222-30. https://doi.org/10.4070/kcj.2016.0312
  13. SYNTAX Working Group. SYNTAX score calculator [Internet]. [place unknown]: SYNTAX Working Group; [cited 2016 September 25]. Available from: http://www.syntaxscore.com.
  14. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005;1:219-27.
  15. Magro M, Nauta S, Simsek C, et al. Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAX score study. Am Heart J 2011;161:771-81. https://doi.org/10.1016/j.ahj.2011.01.004
  16. Farooq V, van Klaveren D, Steyerberg EW, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 2013;381:639-50. https://doi.org/10.1016/S0140-6736(13)60108-7
  17. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996;93:879-88. https://doi.org/10.1161/01.CIR.93.5.879
  18. Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32-5. https://doi.org/10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
  19. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45. https://doi.org/10.2307/2531595
  20. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-72. https://doi.org/10.1002/sim.2929
  21. Tziakas D, Chalikias G, Stakos D, et al. Development of an easily applicable risk score model for contrastinduced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice. Int J Cardiol 2013;163:46-55. https://doi.org/10.1016/j.ijcard.2011.05.079
  22. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-64. https://doi.org/10.1161/01.CIR.0000016043.87291.33
  23. Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005;95:13-9. https://doi.org/10.1016/j.amjcard.2004.08.056
  24. Harjai KJ, Raizada A, Shenoy C, et al. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol 2008;101:812-9. https://doi.org/10.1016/j.amjcard.2007.10.051
  25. Subramaniam RM, Suarez-Cuervo C, Wilson RF, et al. Effectiveness of prevention strategies for contrastinduced nephropathy: a systematic review and meta-analysis. Ann Intern Med 2016;164:406-16. https://doi.org/10.7326/M15-1456
  26. John S, Schmieder RE. Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia. Curr Hypertens Rep 2003;5:199-207. https://doi.org/10.1007/s11906-003-0021-1
  27. Aykan AC, Gul I, Gokdeniz T, et al. Is coronary artery disease complexity valuable in the prediction of contrast induced nephropathy besides Mehran risk score, in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention? Heart Lung Circ 2013;22:836-43. https://doi.org/10.1016/j.hlc.2013.03.085
  28. Fu NK, Yang SC, Chen YL, et al. Risk factors and scoring system in the prediction of contrast induced nephropathy in patients undergoing percutaneous coronary intervention. Zhonghua Yi Xue Za Zhi 2012;92:551-4.
  29. Vuruskan E, Saracoglu E. Bilirubin levels are associated with contrast-induced nephropathy in peripheral artery disease. Angiology 2017;68:728-33. https://doi.org/10.1177/0003319716679340

Cited by

  1. Association of Serum Osmolarity With Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction vol.70, pp.7, 2018, https://doi.org/10.1177/0003319719826466
  2. Residual SYNTAX Score Is Associated With Contrast-Induced Nephropathy in Patients With Non-ST Segment Elevation Myocardial Infarction With Preserved LVEF vol.71, pp.9, 2020, https://doi.org/10.1177/0003319720928673
  3. Evaluation of patients receiving hemodialysis in an emergency service vol.4, pp.11, 2018, https://doi.org/10.28982/josam.747306
  4. Inflammatory Indicators and Hematological Indices in Contrast-Induced Nephropathy Among Patients Receiving Coronary Intervention: A Systematic Review and Meta-Analysis vol.72, pp.9, 2021, https://doi.org/10.1177/00033197211000492
  5. Comparative analysis of four established risk scores for predicting contrast induced acute kidney injury after primary percutaneous coronary interventions vol.37, pp.None, 2018, https://doi.org/10.1016/j.ijcha.2021.100905